The Trump administration, through Health Secretary Robert F. Kennedy Jr., announced the cancellation of nearly $500 million in contracts for mRNA vaccine development. This decision terminates 22 contracts overseen by the Biomedical Advanced Research and Development Authority. Critics oppose the mRNA technology, while many public health experts express alarm over the decision, fearing it undermines future defenses against viruses. Kennedy asserted a commitment to safe vaccines, stating the focus will shift towards alternative solutions rather than mRNA for respiratory viruses. The move has sparked a mix of reactions, with supportive vaccine critics viewing it positively.
The Trump administration is cancelling almost $500 million in contracts to develop mRNA vaccines, which has led to varying responses from public health experts and critics.
Health Secretary Robert F. Kennedy Jr. announced the decision to terminate 22 contracts and stated that HHS supports safe, effective vaccines for Americans.
Michael Osterholm, director of the Center for Infectious Disease Research and Policy, expressed that the termination of mRNA contracts is a dangerous public health judgment with severe consequences.
Mary Holland, president of Children's Health Defense, welcomed the announcement as a positive move towards public health, while advocating for the removal of mRNA vaccines from the market.
Collection
[
|
...
]